Published in Ann Oncol on January 27, 2005
Computer-Based Training in Patients With Post-Chemotherapy Cognitive Impairment | NCT00387062
Further validation of the Multidimensional Fatigue Inventory in a US adult population sample. Popul Health Metr (2009) 1.12
Quality of life and neutropenia in patients with early stage breast cancer: a randomized pilot study comparing additional treatment with mistletoe extract to chemotherapy alone. Breast Cancer (Auckl) (2009) 0.94
The role of IL-1β and TNF-α signaling in the genesis of cancer treatment related symptoms (CTRS): a study using cytokine receptor-deficient mice. Brain Behav Immun (2014) 0.89
Effect of pretreatment distress on daily fatigue after chemotherapy for breast cancer. J Oncol Pract (2008) 0.82
Five-year follow-up of patients with early stage breast cancer after a randomized study comparing additional treatment with viscum album (L.) extract to chemotherapy alone. Breast Cancer (Auckl) (2012) 0.81
The role of specific and core dysfunctional beliefs in breast cancer radiotherapy patients' fatigue. J Health Psychol (2013) 0.77
Multidisciplinary management of breast cancer. Arch Public Health (2016) 0.75
Depression and family support in breast cancer patients. Neuropsychiatr Dis Treat (2017) 0.75
Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma. N Engl J Med (1995) 6.52
Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol (2007) 6.35
Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med (1999) 5.82
The granularity of medical narratives and its effect on the speed and completeness of information retrieval. J Am Med Inform Assoc (1998) 2.03
Medical narratives in electronic medical records. Int J Med Inform (1997) 1.88
Age-specific differences in the diagnostics and treatment of cancer patients aged 50 years and older in the province of Limburg, The Netherlands. Ann Oncol (1996) 1.76
Viridans streptococci isolated from the bloodstream. Relevance of species identification. Diagn Microbiol Infect Dis (1995) 1.46
Home care versus hospital care of patients with hematological malignancies and chemotherapy-induced cytopenia. Ann Oncol (2005) 1.41
Thrombotic and infectious complications of central venous catheters in patients with hematological malignancies. Ann Oncol (2007) 1.41
Interferon treatment of refractory idiopathic thrombocytopenic purpura (ITP) Eur J Haematol (1994) 1.39
Multidrug resistance mediated by P-glycoprotein in haematological malignancies. Neth J Med (1993) 1.38
Incidence, survival and prevalence of myeloid malignancies in Europe. Eur J Cancer (2012) 1.32
MIB-1 labelling index is an independent prognostic marker in primary breast cancer. Br J Cancer (1998) 1.21
Pneumonia due to Micrococcus spp. in a patient with acute myeloid leukaemia. Leukemia (1992) 1.15
Dose-dense epirubicin and paclitaxel with G-CSF: a study of decreasing intervals in metastatic breast cancer. Br J Cancer (2000) 1.11
Prevalence and course of fatigue in breast cancer patients receiving adjuvant chemotherapy. Ann Oncol (2004) 1.10
Patients' decision-making for migraine and chronic daily headache management. A qualitative study. Cephalalgia (2003) 1.09
Value of different modalities of granulocyte-macrophage colony-stimulating factor applied during or after induction therapy of acute myeloid leukemia. J Clin Oncol (1997) 1.04
Comparison of a high-intensity and a low-intensity lumbar extensor training program as minimal intervention treatment in low back pain: a randomized trial. Eur Spine J (2004) 1.03
The role of self-efficacy, recovery self-efficacy, and preparatory planning in predicting short-term smoking relapse. Br J Health Psychol (2011) 0.98
Normal hospital and low-bacterial diet in patients with cytopenia after intensive chemotherapy for hematological malignancy: a study of safety. Ann Oncol (2007) 0.96
Vincristine, doxorubicin and dexamethasone (VAD) administered as rapid intravenous infusion for first-line treatment in untreated multiple myeloma. Br J Haematol (1999) 0.93
Myeloproliferative neoplasia: a review of clinical criteria and treatment. Neth J Med (2012) 0.92
The role of nurses in euthanasia and physician-assisted suicide in The Netherlands. J Med Ethics (2008) 0.92
Gastric low-grade MALT lymphoma, high-grade MALT lymphoma and diffuse large B cell lymphoma show different frequencies of trisomy. Leukemia (1999) 0.92
Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebo-controlled multicenter study. J Clin Oncol (1996) 0.91
The impact of an organ donation registration information program for high school students in the Netherlands. Soc Sci Med (2005) 0.90
Two sides of the medallion: poor treatment tolerance but better survival by standard chemotherapy in elderly patients with advanced-stage diffuse large B-cell lymphoma. Ann Oncol (2011) 0.88
Comparison of A and B-type lamin expression in reactive lymph nodes and nodular sclerosing Hodgkin's disease. Histopathology (1997) 0.88
Invasive aspergillosis in immunocompromised patients: findings on plain film and (HR)CT. Eur J Radiol (1992) 0.87
Psychopathology in adults with 22q11 deletion syndrome and moderate and severe intellectual disability. J Intellect Disabil Res (2014) 0.87
CD44v6 is not a prognostic factor in primary breast cancer. Ann Oncol (1998) 0.87
Intensive chemotherapy to improve outcome in patients with acute lymphoblastic leukemia over the age of 40: a phase II study for efficacy and feasibility by HOVON. Leukemia (2012) 0.86
Comparative study of dose escalation versus interval reduction to obtain dose-intensification of epirubicin and cyclophosphamide with granulocyte colony-stimulating factor in advanced breast cancer. J Clin Oncol (1997) 0.85
Peripheral blood stem cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia? Bone Marrow Transplant (1999) 0.84
Acute lymphoblastic leukaemia in pregnancy. Neth J Med (2005) 0.83
Adjuvant chemohormonal therapy with cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) with or without medroxyprogesterone acetate for node-positive breast cancer patients. Ann Oncol (1993) 0.83
Myelodysplasia presenting with pulmonary manifestations associated with neutrophilic dermatosis. Ann Hematol (1998) 0.83
Quality of life more impaired in younger than in older diffuse large B cell lymphoma survivors compared to a normative population: a study from the population-based PROFILES registry. Ann Hematol (2013) 0.82
Keratinocyte growth factor ameliorates acute graft-versus-host disease in a novel nonmyeloablative haploidentical transplantation model. Bone Marrow Transplant (2005) 0.81
Compensation mechanisms for lost productivity: a comparison between four European countries. Value Health (2013) 0.81
Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma. Leukemia (2005) 0.80
Morphologically normal, CD30-negative B-lymphocytes with chromosome aberrations in classical Hodgkin's disease: the progenitor cell of the malignant clone? J Pathol (1999) 0.80
High-vs low-dose cytarabine combined with interferon alfa in patients with first chronic phase chronic myeloid leukemia. A prospective randomized phase III study. Ann Hematol (2006) 0.79
Clinical practices concerning central venous catheters in haematological patients. Eur J Oncol Nurs (2010) 0.79
Comorbidity and treatment decision-making in elderly non-Hodgkin's lymphoma patients: a survey among haematologists. Neth J Med (2014) 0.79
"Downhill" oesophagus varices: a clue to a serious disease. Neth J Med (1992) 0.79
Proliferation and apoptosis in primary gastric B-cell non-Hodgkin's lymphoma. Histopathology (1997) 0.79
Expression of CD10, CD75 and CD43 in MALT lymphoma and their usefulness in discriminating MALT lymphoma from follicular lymphoma and chronic gastritis. Histopathology (1999) 0.79
Relevance of the expression of bcl-2 in combination with p53 as a prognostic factor in breast cancer. Anticancer Res (1999) 0.79
Home treatment for intensive hematological therapies: who will benefit? Ann Oncol (2006) 0.78
The prognostic significance of steroid receptor activity in tumor tissues of patients with primary breast cancer. Am J Clin Oncol (1997) 0.78
Factors that influence treatment decision-making in elderly DLBCL patients: a case vignette study. Ann Hematol (2015) 0.78
The effect of optimal treatment on elderly patients with aggressive non-Hodgkin's lymphoma: more patients treated with unaffected response rates. Ann Hematol (2001) 0.77
Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy. Breast Cancer Res Treat (2011) 0.77
Treatment of elderly patients with intermediate- and high-grade non-Hodgkin's lymphoma: a retrospective population-based study. Ann Hematol (2001) 0.77
Chromosomal abnormalities in Hodgkin's disease are not restricted to Hodgkin/Reed-Sternberg cells. J Pathol (1998) 0.77
Cell turnover parameters in small and large cell varieties of primary intestinal non-Hodgkin's lymphoma. Cancer (1998) 0.77
Concentrated citrate locking in order to reduce the long-term complications of central venous catheters: a randomized controlled trial in patients with hematological malignancies. Support Care Cancer (2014) 0.77
The use of thalidomide in chronic refractory graft versus host disease. Neth J Med (2001) 0.77
Temporal relationship between HHV 6 and graft vs host disease in a patient after haplo-identical SCT and severe T-cell depletion. Bone Marrow Transplant (2010) 0.77
Intensive postremission chemotherapy without maintenance therapy in adults with acute lymphoblastic leukemia. Dutch Hemato-Oncology Research Group. J Clin Oncol (1997) 0.76
HLA-matched allo-SCT after reduced intensity conditioning with fludarabine/CY in patients with metastatic breast cancer. Bone Marrow Transplant (2009) 0.76
Elderly multiple myeloma patients experience less deterioration in health-related quality of life than younger patients compared to a normative population: a study from the population-based PROFILES registry. Ann Hematol (2014) 0.76
How to encourage smokers to participate in web-based computer-tailored smoking cessation programs: a comparison of different recruitment strategies. Health Educ Res (2013) 0.76
pS2 is an independent prognostic factor for post-relapse survival in primary breast cancer. Anticancer Res (1998) 0.76
Complex chromosome 9, 20, and 22 rearrangements in acute lymphoblastic leukemia with duplication of BCR and ABL sequences. Cancer Genet Cytogenet (2000) 0.76
Study of Stomatococcus mucilaginosus isolated in a hospital ward using phenotypic characterization. Eur J Clin Microbiol Infect Dis (1995) 0.75
Spinal epidural abscess due to Aspergillus infection of the vertebrae: report of 3 cases. Neth J Med (1996) 0.75
Flow cytometric analysis of consecutive lymph node samples from patients with Hodgkin's disease: reproducible within one biopsy? Leuk Lymphoma (1996) 0.75
Non-myeloablative allogeneic stem cell transplantation: a new treatment option for acquired angioedema? Neth J Med (2015) 0.75
DNA aneuploidy and cell proliferation in relation to histology and prognosis in patients with Hodgkin's disease. Ann Oncol (1993) 0.75
Three-Layer Model for the design of a Protocol Support System. Int J Med Inform (2005) 0.75
DNA aneuploidy in Hodgkin's disease: a multiparameter flow cytometric analysis. Leuk Lymphoma (1994) 0.75
[The quality of life after stem cell transplantation: problems with fatigue, sexuality, finances and employment]. Ned Tijdschr Geneeskd (1998) 0.75
Specific detection of Helicobacter pylori and non-Helicobacter pylori flora in small- and large-cell primary gastric B-cell non-Hodgkin's lymphoma. Ann Oncol (1997) 0.75
Prognostic and predictive factors in breast cancer. Neth J Med (1997) 0.75
The full length genomic sequence of a novel HLA-C*03 allele: HLA-C*03:219. Tissue Antigens (2014) 0.75
Acute tumour lysis syndrome in a patient with acute lymphoblastic leukemia after a single dose of prednisone. Br J Haematol (1991) 0.75
The PropeR way to support medical doctors in daily practice. Developing the protocol based DSS. Stud Health Technol Inform (2003) 0.75
Autologous bone marrow transplantation for low-grade non-Hodgkin's lymphoma: the European Bone Marrow Transplant Group experience. EBMT Working Party for Lymphoma. Ann Oncol (1994) 0.75
High-dose chemotherapy with autologous bone marrow support as consolidation after standard-dose adjuvant therapy in primary breast cancer patients with seven or more involved axillary lymph nodes. Bone Marrow Transplant (1998) 0.75
Advantages and limitations of (non-)myeloablative allogeneic stem cell transplantation. Neth J Med (2002) 0.75
P53 as a marker of the malignant cell in Hodgkin's disease. Ann Oncol (1994) 0.75
Graft-versus-tumor effects on murine mammary carcinoma in a model of nonmyeloablative haploidentical stem cell transplantation. Bone Marrow Transplant (2006) 0.75
The reliability and value of determining mediastinal involvement and width on chest radiographs in patients with Hodgkin's disease. Eur J Radiol (1993) 0.75
Intermediate and high grade non Hodgkin's lymphoma in the elderly. Leuk Lymphoma (1999) 0.75
Acute lymphoblastic leukaemia in adults: immunological subtypes and clinical features at presentation. Ann Hematol (1993) 0.75
Invasive Aspergillus infections in patients with a malignancy: description of an outbreak and overview of the literature. Neth J Med (1992) 0.75
Phase II study of intensive chemotherapy with autologous bone marrow transplantation in patients in complete remission of disseminated breast cancer. Breast Cancer Res Treat (1996) 0.75
Comparison of image (CAS 200) and flow cytometry determined DNA content of paraffin-embedded Hodgkin's disease tissue. Hematol Pathol (1994) 0.75
Non-myeloablative allogeneic stem cell transplantation in patients with solid tumours and patients with a haematological malignancy. Neth J Med (2002) 0.75